VIVUS Inc. VVUS was a big mover last session, as the company saw its shares rally over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $4.84 to $5.36 in the past one-month time frame.
In the last 30 days, the company witnessed no estimate revisions, while the Zacks Consensus Estimate, pegged at a loss, widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.
VIVUS currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other attractive players in the healthcare industry include Enanta Pharmaceuticals, Inc. ENTA, Gilead Sciences Inc. GILD and TrovaGene, Inc. TROV all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ENANTA PHARMA ENTA: Free Stock Analysis Report
GILEAD SCIENCES GILD: Free Stock Analysis Report
TROVAGENE INC TROV: Get Free Report
VIVUS INC VVUS: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
